Taylor Ann M, Phillips Kristine, Patel Kushang V, Turk Dennis C, Dworkin Robert H, Beaton Dorcas, Clauw Daniel J, Gignac Monique A M, Markman John D, Williams David A, Bujanover Shay, Burke Laurie B, Carr Daniel B, Choy Ernest H, Conaghan Philip G, Cowan Penney, Farrar John T, Freeman Roy, Gewandter Jennifer, Gilron Ian, Goli Veeraindar, Gover Tony D, Haddox J David, Kerns Robert D, Kopecky Ernest A, Lee David A, Malamut Richard, Mease Philip, Rappaport Bob A, Simon Lee S, Singh Jasvinder A, Smith Shannon M, Strand Vibeke, Tugwell Peter, Vanhove Gertrude F, Veasley Christin, Walco Gary A, Wasan Ajay D, Witter James
Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Pain. 2016 Sep;157(9):1836-1850. doi: 10.1097/j.pain.0000000000000577.
Although pain reduction is commonly the primary outcome in chronic pain clinical trials, physical functioning is also important. A challenge in designing chronic pain trials to determine efficacy and effectiveness of therapies is obtaining appropriate information about the impact of an intervention on physical function. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) and Outcome Measures in Rheumatology (OMERACT) convened a meeting to consider assessment of physical functioning and participation in research on chronic pain. The primary purpose of this article is to synthesize evidence on the scope of physical functioning to inform work on refining physical function outcome measurement. We address issues in assessing this broad construct and provide examples of frequently used measures of relevant concepts. Investigators can assess physical functioning using patient-reported outcome (PRO), performance-based, and objective measures of activity. This article aims to provide support for the use of these measures, covering broad aspects of functioning, including work participation, social participation, and caregiver burden, which researchers should consider when designing chronic pain clinical trials. Investigators should consider the inclusion of both PROs and performance-based measures as they provide different but also important complementary information. The development and use of reliable and valid PROs and performance-based measures of physical functioning may expedite development of treatments, and standardization of these measures has the potential to facilitate comparison across studies. We provide recommendations regarding important domains to stimulate research to develop tools that are more robust, address consistency and standardization, and engage patients early in tool development.
尽管疼痛减轻通常是慢性疼痛临床试验的主要结果,但身体功能也很重要。设计慢性疼痛试验以确定治疗方法的疗效和有效性时面临的一个挑战是获取有关干预措施对身体功能影响的适当信息。临床试验中的方法、测量与疼痛评估倡议组织(IMMPACT)和风湿病学疗效指标组织(OMERACT)召开了一次会议,以审议身体功能评估以及参与慢性疼痛研究的相关事宜。本文的主要目的是综合关于身体功能范围的证据,为完善身体功能结局测量的工作提供参考。我们讨论了评估这一广泛概念时存在的问题,并提供了相关概念常用测量方法的示例。研究人员可以使用患者报告结局(PRO)、基于表现的测量方法以及活动的客观测量方法来评估身体功能。本文旨在为使用这些测量方法提供支持,涵盖功能的广泛方面,包括工作参与、社会参与和照料者负担,研究人员在设计慢性疼痛临床试验时应予以考虑。研究人员应考虑纳入PRO和基于表现的测量方法,因为它们提供了不同但同样重要的补充信息。开发和使用可靠且有效的身体功能PRO和基于表现的测量方法可能会加快治疗方法的研发,这些测量方法的标准化有可能促进不同研究之间的比较。我们就重要领域提出建议,以推动开发更完善、解决一致性和标准化问题并让患者尽早参与工具开发的研究。